These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16300709)

  • 21. [Treatment experience with metformin in polycystic ovary syndrome].
    Petrányi G
    Orv Hetil; 2005 May; 146(21):1151-5. PubMed ID: 15991679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA; Bradley HM; McCormick C; Witkop CT
    Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
    Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
    Goldenberg N; Glueck C
    Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
    Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
    Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does metformin induce ovulation in normoandrogenic anovulatory women?
    Carmina E; Lobo RA
    Am J Obstet Gynecol; 2004 Nov; 191(5):1580-4. PubMed ID: 15547527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effects of metformin in patients with polcystic ovarian syndrome].
    Galindo CG; Hernández I; Ayala AR
    Ginecol Obstet Mex; 2007 Apr; 75(4):181-6. PubMed ID: 17849796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
    Leeman L; Acharya U
    J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J; Starczewski A
    Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.
    Rashidi B; Haghollahi F; Shariat M; Zayerii F
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):142-7. PubMed ID: 19574176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy.
    Kovo M; Weissman A; Gur D; Levran D; Rotmensch S; Glezerman M
    J Matern Fetal Neonatal Med; 2006 Jul; 19(7):415-9. PubMed ID: 16923696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.